metaMe Health partners with Indegene to launch Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with Irritable Bowel Syndrome PRINCETON, N.J. and CHICAGO, March 22, 2022 (GLOBE NEWSWIRE) -- Indegene, a technology-led global healthcare solutions provider, and metaMe Health, Inc. (metaMe), a Prescription Digital Therapeutics...

Aedesius Health and its lead biopharma company, AO BIO partner with Indegene for a comprehensive commercialization engagement MONTGOMERY, Ala. and PRINCETON, N.J. and LONDON and BANGALORE, India, March 01, 2022 (GLOBE NEWSWIRE) -- Aedesius Health, a division of AedesiusOne Ltd, and its biopharmaceutical development...

Woodward Pharma Services Selects Indegene Co-Promotion To Grow Its Revenue And Enhance The Brand Experience PRINCETON, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Woodward Pharma Services LLC, a Michigan-based specialty pharmaceutical company, today announced a partnership with Indegene, a technology-led...

Indegene and ConTIPI Medical Ltd partner to bring innovative disposable non-surgical device to market to help women suffering from Pelvic Organ Prolapse (POP) PRINCETON, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Indegene, a global enterprise healthtech solutions company and ConTIPI Medical Ltd, an innovator in the field of providing non-surgical and...

Alfasigma USA, Inc. Engages Indegene, Inc. to Expand the Promotion of ZELNORM® to Healthcare Professionals in the United States BEDMINSTER, N.J., July 23, 2020 (GLOBE NEWSWIRE) -- Alfasigma USA, Inc. today announced a strategic deal with Indegene, Inc., a global life sciences and healthcare solutions provider, to co-promote...